Research project · Horizon Europe

ThrombUS+

Wearable continuous point-of-care monitoring, risk estimation and prevention for deep vein thrombosis. TELEMED is one of 18 partners from eight countries developing a wearable system that helps detect and prevent blood clots in bedridden patients.

€9.5 M

Project budget

18

Partners from 8 countries

42 months

January 2024 – June 2027

101137227

Grant agreement

The challenge

Deep vein thrombosis (DVT) is a condition in which blood clots form in the deep veins, most often in the legs. If a clot breaks off, it can travel to the lungs and cause a pulmonary embolism, which can be life-threatening.

DVT is hard to diagnose: episodes are often silent, without any symptoms. Patients who spend long periods in bed are especially at risk.

The solution

ThrombUS+ is developing a wearable system that continuously monitors the legs of bedridden patients. Artificial intelligence analyses data from three types of sensors: ultrasound, bioimpedance plethysmography and light reflectance rheography.

To help prevent clots, patients are encouraged to move their limbs while playing serious computer games. The project will also generate large datasets to train and test the AI algorithms in large-scale clinical trials.

TELEMED’s role

[Describe TELEMED’s contribution to the project in 2–3 sentences — for example, the ultrasound technology, work packages or tasks TELEMED is responsible for.]

Consortium

Partners from Greece, Lithuania, France, Germany, the USA, Italy, Finland and Spain, coordinated by the ATHENA Research and Innovation Centre in Greece.

Coordinator
ATHENA Research and Innovation Centre in Information, Communication and Knowledge Technologies (Greece)
Partners include
VERMON SA, TELEMED UAB, Tampere University of Applied Sciences, Lithuanian University of Health Sciences, Kaunas University of Technology, Fraunhofer-Gesellschaft — see all partners
Programme
Horizon Europe — EU research and innovation programme
Duration
1 January 2024 – 30 June 2027
Funded by the European Union

Funded by the European Union under grant agreement No. 101137227. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the granting authority. Neither the European Union nor the granting authority can be held responsible for them.

Interested in ultrasound for wearable or point-of-care devices?

Our OEM beamformers and SDK are built for integration into new medical devices.

OEM beamformers